STAT3 and non-small cell lung carcinoma: miR-874-3p can inhibit STAT3 in several cancers, including GC (Zhang et al., 2015), CRC (Zhao and Dong, 2016), NSCLC (Bu et al., 2020), and ESCC (Yuan et al., 2018).